223 related articles for article (PubMed ID: 21592581)
21. Toll-like receptor 9 in murine lupus: more friend than foe!
Yu P; Musette P; Peng SL
Immunobiology; 2008; 213(2):151-7. PubMed ID: 18241699
[TBL] [Abstract][Full Text] [Related]
22. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
23. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control Th17 cells and severe autoimmunity.
Stoehr AD; Schoen CT; Mertes MM; Eiglmeier S; Holecska V; Lorenz AK; Schommartz T; Schoen AL; Hess C; Winkler A; Wardemann H; Ehlers M
J Immunol; 2011 Sep; 187(6):2953-65. PubMed ID: 21859955
[TBL] [Abstract][Full Text] [Related]
24. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population.
Tao K; Fujii M; Tsukumo S; Maekawa Y; Kishihara K; Kimoto Y; Horiuchi T; Hisaeda H; Akira S; Kagami S; Yasutomo K
Ann Rheum Dis; 2007 Jul; 66(7):905-9. PubMed ID: 17344245
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the requirements for cognate T cell help for IgG anti-double-stranded DNA antibody production in vitro: T helper-derived lymphokines replace T cell cloned lines for B cells from NZB.H-2bm12 but not B6.H-2bm12 mice.
Cawley D; Chiang BL; Naiki M; Ansari AA; Gershwin ME
J Immunol; 1993 Mar; 150(6):2467-77. PubMed ID: 8450223
[TBL] [Abstract][Full Text] [Related]
26. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
27. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
28. Idiotype-specific Th cells support oligoclonal expansion of anti-dsDNA B cells in mice with lupus.
Aas-Hanssen K; Funderud A; Thompson KM; Bogen B; Munthe LA
J Immunol; 2014 Sep; 193(6):2691-8. PubMed ID: 25127856
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of singlet oxygen modified human DNA: implications for anti-DNA antibodies in systemic lupus erythematosus.
Al Arfaj AS; Chowdhary AR; Khalil N; Ali R
Clin Immunol; 2007 Jul; 124(1):83-9. PubMed ID: 17540620
[TBL] [Abstract][Full Text] [Related]
30. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
31. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
32. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
33. Chronical administration of anti-DNA antibodies by subcutaneous injection of hybridoma clones in BALB/c and NZBxNZW/F1 mice. Experimental model of the pathogenic role of DNA in acute lupus disease.
Gayral-Taminh M; Delobbe I; Mignon-Conte MA; Dueymes M; Conte JJ
J Clin Lab Immunol; 1992; 38(3):111-35. PubMed ID: 1345749
[TBL] [Abstract][Full Text] [Related]
34. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
35. Studies on the structure, regulation, and pathogenic potential of anti-dsDNA antibodies.
Spatz L; Iliev A; Saenko V; Jones L; Irigoyen M; Manheimer-Lory A; Gaynor B; Putterman C; Bynoe M; Kowal C; Kuo P; Newman J; Diamond B
Methods; 1997 Jan; 11(1):70-8. PubMed ID: 8990091
[TBL] [Abstract][Full Text] [Related]
36. Ganglioside GQ1b enhances anti-double-stranded DNA antibody and IgG production of PBMCs from patients with systemic lupus erythematosus.
Kanda N; Watanabe S
J Allergy Clin Immunol; 2000 Mar; 105(3):532-40. PubMed ID: 10719304
[TBL] [Abstract][Full Text] [Related]
37. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
38. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
[TBL] [Abstract][Full Text] [Related]
39. Antigen-specific immature dendritic cell vaccine ameliorates anti-dsDNA antibody-induced renal damage in a mouse model.
Xia Y; Jiang S; Weng S; Lv X; Cheng H; Fang C
Rheumatology (Oxford); 2011 Dec; 50(12):2187-96. PubMed ID: 21933790
[TBL] [Abstract][Full Text] [Related]
40. Initiation of systemic autoimmunity and sequence specific anti-DNA autoantibodies.
Radic MZ; Cocca BA; Seal SN
Crit Rev Immunol; 1999; 19(2):117-26. PubMed ID: 10352900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]